Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal <i>Haemophilus influenzae</i> protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.

Vaccine X · 2021 · PMC7930582 · PMID 33681756

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Higher GMTs in the S SS P group against serotypes 3 and 19A (GMT ratios 1.35 and 1.05) did not reach statistical significance, whereas serotype 6A GMT was significantly lower (GMT ratio 0.37) ( Table 6 and Fig. 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.